Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases
- PMID: 23185418
- PMCID: PMC3502255
- DOI: 10.1371/journal.pone.0049726
Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases
Abstract
Introduction: Microvesicles (MVs), earlier referred to as microparticles, represent a major type of extracellular vesicles currently considered as novel biomarkers in various clinical settings such as autoimmune disorders. However, the analysis of MVs in body fluids has not been fully standardized yet, and there are numerous pitfalls that hinder the correct assessment of these structures.
Methods: In this study, we analyzed synovial fluid (SF) samples of patients with osteoarthritis (OA), rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). To assess factors that may confound MV detection in joint diseases, we used electron microscopy (EM), Nanoparticle Tracking Analysis (NTA) and mass spectrometry (MS). For flow cytometry, a method commonly used for phenotyping and enumeration of MVs, we combined recent advances in the field, and used a novel approach of differential detergent lysis for the exclusion of MV-mimicking non-vesicular signals.
Results: EM and NTA showed that substantial amounts of particles other than MVs were present in SF samples. Beyond known MV-associated proteins, MS analysis also revealed abundant plasma- and immune complex-related proteins in MV preparations. Applying improved flow cytometric analysis, we demonstrate for the first time that CD3(+) and CD8(+) T-cell derived SF MVs are highly elevated in patients with RA compared to OA patients (p=0.027 and p=0.009, respectively, after Bonferroni corrections). In JIA, we identified reduced numbers of B cell-derived MVs (p=0.009, after Bonferroni correction).
Conclusions: Our results suggest that improved flow cytometric assessment of MVs facilitates the detection of previously unrecognized disease-associated vesicular signatures.
Conflict of interest statement
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3502255/bin/pone.0049726.g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3502255/bin/pone.0049726.g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3502255/bin/pone.0049726.g003.gif)
Similar articles
-
Enumeration and phenotyping of circulating microvesicles by flow cytometry and nanoparticle tracking analysis: Plasma versus serum.Int J Lab Hematol. 2021 Jun;43(3):506-514. doi: 10.1111/ijlh.13407. Epub 2020 Nov 27. Int J Lab Hematol. 2021. PMID: 33244869
-
Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis.Rheumatol Int. 2019 Aug;39(8):1377-1387. doi: 10.1007/s00296-019-04337-1. Epub 2019 Jun 14. Rheumatol Int. 2019. PMID: 31201512
-
Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis.Rheumatol Int. 2009 Jun;29(8):907-11. doi: 10.1007/s00296-008-0805-3. Epub 2008 Dec 4. Rheumatol Int. 2009. PMID: 19052752
-
Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery.Crit Rev Clin Lab Sci. 2017 Nov-Dec;54(7-8):495-505. doi: 10.1080/10408363.2017.1408561. Epub 2017 Dec 4. Crit Rev Clin Lab Sci. 2017. PMID: 29202618 Review.
-
Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases.Genomics Proteomics Bioinformatics. 2018 Feb;16(1):50-62. doi: 10.1016/j.gpb.2017.03.006. Epub 2018 Feb 17. Genomics Proteomics Bioinformatics. 2018. PMID: 29462670 Free PMC article. Review.
Cited by
-
Extracellular vesicles as tools and targets in therapy for diseases.Signal Transduct Target Ther. 2024 Feb 5;9(1):27. doi: 10.1038/s41392-024-01735-1. Signal Transduct Target Ther. 2024. PMID: 38311623 Free PMC article. Review.
-
The Role of Extracellular Vesicles in the Pathogenesis and Treatment of Rheumatoid Arthritis and Osteoarthritis.Cells. 2023 Nov 27;12(23):2716. doi: 10.3390/cells12232716. Cells. 2023. PMID: 38067147 Free PMC article. Review.
-
Comparative effect of platelet- and mesenchymal stromal cell-derived extracellular vesicles on human cartilage explants using an ex vivo inflammatory osteoarthritis model.Bone Joint Res. 2023 Oct 19;12(10):667-676. doi: 10.1302/2046-3758.1210.BJR-2023-0109.R1. Bone Joint Res. 2023. PMID: 37852621 Free PMC article.
-
Platelet Activation in Ovarian Cancer Ascites: Assessment of GPIIb/IIIa and PF4 in Small Extracellular Vesicles by Nano-Flow Cytometry Analysis.Cancers (Basel). 2022 Aug 24;14(17):4100. doi: 10.3390/cancers14174100. Cancers (Basel). 2022. PMID: 36077635 Free PMC article.
-
Exosomes in osteoarthritis: Updated insights on pathogenesis, diagnosis, and treatment.Front Cell Dev Biol. 2022 Jul 26;10:949690. doi: 10.3389/fcell.2022.949690. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35959489 Free PMC article. Review.
References
-
- Gyorgy B, Modos K, Pallinger E, Paloczi K, Pasztoi M, et al. (2011) Detection and isolation of cell-derived microparticles are compromised by protein complexes due to shared biophysical parameters. Blood. 117: e39–48. - PubMed
-
- Artoni A, Merati G, Padovan L, Scalambrino E, Chantarangkul V, et al. (2012) Residual platelets are the main determinants of microparticles count in frozen-thawed plasma. Thromb Res. 130: 561–2. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials